SyReflux (Syntrion GmbH)


Welcome to the PulseAid listing for the SyReflux drug offered from Syntrion GmbH. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Syntrion GmbH
NON-PROPRIETARY NAME: PENICILLIUM ROQUEFORTI
SUBSTANCE NAME: PENICILLIUM ROQUEFORTI
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-02-11
END MARKETING DATE: 2020-08-31


SyReflux HUMAN OTC DRUG Details:

Item DescriptionSyReflux from Syntrion GmbH
LABELER NAME: Syntrion GmbH
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 2015-02-11
END MARKETING DATE: 2020-08-31
PRODUCT ID: 10424-109_294b5c0a-b16c-4adb-b0f1-ce8214bd163d
PRODUCT NDC: 10424-109
APPLICATION NUMBER:

Other PENICILLIUM ROQUEFORTI Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Antigen Laboratories, Inc.Penicillium roquefortii
sanPharma GmbHRoquefoSAN
Sanum Kehlbeck GmbH & Co. KGPleo Fort
Sanum-Kehlbeck GmbH & Co. KGPleo Fort
SymbiopathicSYMBIO FORTI DROPS
Syntrion GmbHSyReflux
USPharmaCoRoqueforti